GMP Synthesis of Bulk Drug Testing
Closed Special Notice Posted
This opportunity was awarded. See the award notice from .
- Solicitation number
- 75N95024R00058
- Agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Place of performance
- Bethesda, Maryland, United States
Notice details come from SAM.gov. Updated .
About this opportunity
This Special Notice was published by the Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse (NIDA). It is an amendment to a Request for Proposals (RFP) for the "GMP Synthesis of Bulk Drug Substances" solicitation, number 75N95024R00058.
The purpose of this amendment is to clarify the RFP requirements by responding to questions submitted by potential offerors. It specifies that the batches referenced in the RFP pertain to individual molecules, not splits between multiple compounds. The contractor's Principal Investigator will oversee the project, and the contractor will produce material for research conducted by NIDA or a group supported by NIDA. Small business subcontracting plans are not required from small business companies bidding on this requirement. All other terms and conditions of the RFP remain unchanged, and the proposal due date is unchanged at May 3, 2024 at 3:00 PM Eastern Time.
Notice text
The purpose of this amendment # 01 is to clarify the RFP requirements by responding to questions submitted. Please see the Attachment for more details.
Files
| File | Type | Posted |
|---|---|---|
| Amendment01_75N95024R00058.pdf |
Notice history
| Notice | Type | Posted |
|---|---|---|
| GMP Synthesis of Bulk Drug Testing | Award Notice | |
| This notice | Special Notice | |
| GMP Synthesis of Bulk Drug Testing | Solicitation | |
| GMP Synthesis of Bulk Drug Testing | Pre-Solicitation | |
| GMP Synthesis of Bulk Drug Testing | Pre-Solicitation |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| Tau radiotracers for Baltimore Longitudinal Study of Aging | National Institute on Drug Abuse | No set-aside | |
| NOI - B2B Award entitled - Developing Red Cell-Sp | Office of Logisitics and Acquisition Operations | No set-aside | |
| Methylphenidate ER | Medical Supply Chain | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity